| Determinants of resistance to engineered T cell therapies targeting CD19 in large B cell lymphomas BJ Sworder, DM Kurtz, SK Alig, MJ Frank, N Shukla, A Garofalo, ... Cancer cell 41 (1), 210-225. e5, 2023 | 83 | 2023 |
| Association between age and nodal metastasis in papillary thyroid carcinoma N Shukla, N Osazuwa-Peters, UC Megwalu Otolaryngology–Head and Neck Surgery 165 (1), 43-49, 2021 | 52 | 2021 |
| Distinct Hodgkin lymphoma subtypes defined by noninvasive genomic profiling SK Alig, M Shahrokh Esfahani, A Garofalo, MY Li, C Rossi, T Flerlage, ... Nature 625 (7996), 778-787, 2024 | 49 | 2024 |
| Laser interstitial thermal therapy for the treatment of epilepsy: evidence to date ND Shukla, AL Ho, AV Pendharkar, ES Sussman, CH Halpern Neuropsychiatric disease and treatment, 2469-2475, 2017 | 35 | 2017 |
| Nectin-1-specific entry of herpes simplex virus 1 is sufficient for infection of the cornea and viral spread to the trigeminal ganglia ND Shukla, V Tiwari, T Valyi-Nagy Molecular vision 18, 2711, 2012 | 35 | 2012 |
| Efficacy of checkpoint inhibition after CAR-T failure in aggressive B-cell lymphomas: outcomes from 15 US institutions A Major, J Yu, N Shukla, Y Che, TG Karrison, R Treitman, MK Kamdar, ... Blood advances 7 (16), 4528-4538, 2023 | 22 | 2023 |
| Universal screening of gastrointestinal malignancies for mismatch repair deficiency at Stanford A Abrha, ND Shukla, R Hodan, T Longacre, S Raghavan, CC Pritchard, ... JNCI Cancer Spectrum 4 (5), pkaa054, 2020 | 20 | 2020 |
| Functional outcomes of septal extension grafting in aesthetic rhinoplasty: a cohort analysis PN Patel, M Abdelwahab, ND Shukla, H Wadwha, DR Grimm, ... Facial Plastic Surgery & Aesthetic Medicine 23 (3), 172-179, 2021 | 15 | 2021 |
| The role of insurance status as a mediator of racial disparities in oropharyngeal cancer outcomes N Shukla, Y Ma, UC Megwalu Head & Neck 43 (10), 3116-3124, 2021 | 11 | 2021 |
| The cup runneth over: treatment strategies for newly diagnosed acute myeloid leukemia JH Cooperrider, N Shukla, MT Nawas, AA Patel JCO Oncology Practice 19 (2), 74-85, 2023 | 8 | 2023 |
| Poor survival outcomes of checkpoint inhibitors for B-cell lymphomas relapsing after or refractory to CAR T-cell therapy: a real-world cohort from 15 US academic institutions A Major, J Yu, ND Shukla, R Treitman, MK Kamdar, BM Haverkos, ... Blood 140 (Supplement 1), 1328-1331, 2022 | 6 | 2022 |
| Metastatic Parotid Gland Carcinoma With ERBB2 Amplification With Complete Response to Fam‐Trastuzumab Deruxtecan ND Shukla, RS Chiang, AD Colevas Journal of the National Comprehensive Cancer Network 20 (2), 102-104, 2022 | 5 | 2022 |
| Functional screening of amplification outlier oncogenes in organoid models of early tumorigenesis AA Salahudeen, JA Seoane, K Yuki, AT Mah, AR Smith, K Kolahi, M Sean, ... Cell reports 42 (11), 2023 | 4 | 2023 |
| DETERMINANTS OF RESISTANCE TO ENGINEERED T‐CELL THERAPIES TARGETING CD19 IN LYMPHOMA B Sworder, DM Kurtz, S Alig, MJ Frank, CW Macauley, A Garofalo, ... Hematological Oncology 39, 2021 | 4 | 2021 |
| Profiling T-cell receptor diversity and dynamics during lymphoma immunotherapy using cell-free DNA (cfDNA) ND Shukla, AFM Craig, B Sworder, DM Kurtz, C Macaulay, A Garofalo, ... Blood 136, 49-50, 2020 | 3 | 2020 |
| Prevalence and molecular etiology of mismatch repair deficiency among gastrointestinal cancers. N Shukla, A Abrha, TA Longacre, R Koff, JM Ford, GA Fisher, ... Journal of Clinical Oncology 37 (4_suppl), 215-215, 2019 | 3 | 2019 |
| Specificity of immunoglobulin high-throughput sequencing minimal residual disease monitoring in non-Hodgkin lymphomas ND Shukla, JG Schroers-Martin, BJ Sworder, KR Kathuria, SK Alig, ... Blood Advances 8 (3), 780-784, 2024 | 2 | 2024 |
| Measurable residual disease conversion rate with consolidation chemotherapy in acute myeloid leukemia D Gaut, C Oliai, J Boiarsky, S Zhang, A Salhotra, T Azenkot, VE Kennedy, ... Leukemia & Lymphoma 65 (1), 69-77, 2024 | 2 | 2024 |
| Pan-cancer organoid validation of tumor outlier chromosomal amplification events AA Salahudeen, K Yuki, JA Seoane, AT Mah, AR Smith, K Kolahi, ... bioRxiv, 2021.10. 05.463147, 2021 | 1 | 2021 |
| Update on International Cooperative Groups Studies in Thoracic Malignancies: The Emergence of Immunotherapy ND Shukla, AA Salahudeen, GA Taylor, SS Ramalingam, EE Vokes, ... Clinical lung cancer 19 (5), 377-386, 2018 | 1 | 2018 |
